Intelligence · Clinical Development
Pipeline search results
Programs matching “Astra” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 467 pipeline programs matching "Astra" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
A Study to Evaluate MEDI5752 in Subjects with Advanced Solid Tumors
AstraZeneca AB
Advanced solid tumours
1 trial -
A trial to learn how baxdrostat affects the heartbeat in healthy participants
AstraZeneca AB
Treatment-resistant hypertension, Primary aldosteronism, Uncontrolled hypertension
1 trial -
AZD0449
AstraZeneca
Asthma
1 trial -
AZD0530
AstraZeneca
Solid Tumor
1 trial -
AZD3514
AstraZeneca
Prostate Cancer
1 trial -
AZD5462-D9090C00012
AstraZeneca AB
Chronic Heart Failure
1 trial -
AZD5492
AstraZeneca AB
B-Cell Malignancies
1 trial -
AZD6244
AstraZeneca
Neoplasms,
1 trial -
AZD7762
AstraZeneca
Cancer
1 trial -
An Ophthalmic Safety Study of New Investigational Drug in Breast Cancer Patients
AstraZeneca AB
Breast Cancer
1 trial -
BET-PSMA-001
Blue Earth Diagnostics Ireland Ltd
PSMA-positive non-curative metastatic castration-resistant prostate cancer
1 trial -
BPX-601
Regeneron UK Limited
Metastatic Castration-resistant Prostate Cancer
1 trial -
Benralizumab
AstraZeneca
Healthy Subjects
1 trial -
C2321001
Pfizer Australia Pty Ltd
Castration Resistant Prostate Cancer (CRPC), Follicular Lymphoma (FL), Small Cell Lung Cancer (SCLC), Diffuse Large B-Cell Lymphoma (DLBCL)
1 trial -
C2321006
Pfizer Australia Pty Ltd
Small cell lung cancer, Castration-resistant prostate cancer, Follicular lymphoma
1 trial -
C2321007
Pfizer Australia Pty Ltd
small cell lung cancer (SCLC), castration resistant prostate cancer (CRPC), follicular lymphoma (FL)
1 trial -
CAAA617A12101
Novartis Pharmaceuticals
Metastatic Castration-Resistant Prostate Cancer
1 trial -
Capivasertib
AstraZeneca
Advanced Solid Tumours
1 trial -
Ceralasertib
AstraZeneca
Advanced Solid Malignancies
1 trial -
Cisplatin
AstraZeneca
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
1 trial -
D0816C00025
AstraZeneca AB
solid tumors
1 trial -
D1346C00015
AstraZeneca AB
Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN)
1 trial -
D3560C00817
AstraZeneca AB
Clinical trial healthy volunteer
1 trial -
D3615C00005
AstraZeneca AB
Healthy participants
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.